Filed Pursuant to Rule 424(b)(5)
Registration No. 333-224179
PROSPECTUS SUPPLEMENT
(To Prospectus Dated April 6, 2018)
Up to $286,250,512

Common Stock
We have entered into an At the Market Offering Sales Agreement, as amended, with BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Regions Securities LLC, Fifth Third Securities, Inc., RBC Capital Markets, LLC, BTIG, LLC, Jefferies LLC, Samuel A. Ramirez & Company, Inc. and Robert W. Baird & Co. Incorporated relating to the offering of our common stock, par value $0.01 per share, made by this prospectus supplement and the accompanying prospectus. We refer collectively to BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Regions Securities LLC, Fifth Third Securities, Inc., RBC Capital Markets, LLC, BTIG, LLC, Jefferies LLC, Samuel A. Ramirez & Company, Inc., and Robert W. Baird & Co. Incorporated as the Sales Agents. On October 25, 2019, we further amended the sales agreement to, among other things, add Regions Securities LLC as a Sales Agent. Under the sales agreement, we may from time to time offer and sell shares of our common stock having an aggregate offering price of up to $450,000,000 through one or more of the Sales Agents. Prior to the date of this prospectus supplement, we had already sold shares of our common stock having an aggregate offering price of $163,749,488 under the sales agreement, resulting in shares of our common stock having an aggregate offering price of up to $286,250,512 remaining available for sale pursuant to the terms of the sales agreement.
Sales of the shares of our common stock under this prospectus supplement, if any, will be on or through the facilities of the New York Stock Exchange, or the NYSE, or any other existing trading market, or to or through a market maker or through an electronic communications network, or in any other manner permitted by law (including, without limitation, privately negotiated transactions) at prices prevailing at the time of sale or negotiated transactions, or as otherwise agreed with the Sales Agents.
The Sales Agents will be entitled to compensation in an agreed amount not to exceed 2.0% of the gross sales price per share for any shares of our common stock sold from time to time under the sales agreement.
Subject to the terms and conditions of the sales agreement, the applicable Sales Agent will use its commercially reasonable efforts to sell on our behalf any shares of common stock to be offered by us under the sales agreement. The offering of our common stock pursuant to the sales agreement will terminate upon the earlier of (1) the sale of all the shares of our common stock subject to the sales agreement and (2) the termination of the sales agreement by the Sales Agents or us.
Our common stock is listed on the NYSE under the symbol “SUI.” On October 24, 2019, the last reported sale price of our common stock on the NYSE was $158.46.
Investing in our common stock involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading “Risk Factors” on pageS-5 of this prospectus supplement and page 3 of the accompanying prospectus, and the documents incorporated by reference therein.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | | | | | | | | | | | |
BMO Capital Markets | | | | | | | | | | | | | | |
| | BofA Merrill Lynch | | | | | | | | | | | | |
| | | | Citigroup | | | | | | | | | | |
| | | | | | Regions Securities LLC | | | | | | | | |
| | | | | | | | Fifth Third Securities | | | | | | |
| | | | | | | | | | RBC Capital Markets | | | | |
| | | | | | | | | | | | BTIG | | | | | | |
| | | | | | | | | | | | | | Jefferies | | | | |
| | | | | | | | | | | | | | | | Ramirez & Co., Inc. |
| | | | | | | | | | | | | | | | | | Baird |
The date of this prospectus supplement is October 25, 2019.